Effects of dopexamine on lipid peroxidation during aortic surgery in pigs: comparison with dopamine.
OBJECTIVE
We investigated the dose-related effect of dopexamine and dopamine on free radical production and lipid peroxidation estimated by MDA measurements in an ischaemia-reperfusion model of supraceliac aortic repair.


METHODS
Prospective, randomized, blinded experimental study.


METHODS
Twenty-five healthy pigs.


METHODS
All experiments were performed under general endotracheal anaesthesia. Supraceliac aortic cross clamping was performed in all pigs. The pigs were randomly assigned into five groups (n=5 in each group) and received a continuous intravenous infusion of normal saline (CTL), dopamine 2 microg kg(-1)min(-1) (dopa 2), dopamine 8 microg kg(-1)min(-1) (dopa 8), dopexamine 2 microg kg(-1)min(-1) (dopex 2), dopexamine 8 microg kg(-1)min(-1) (dopex 8). Cardiac output, mean arterial pressure, arterial blood gas analysis and blood sampling for plasma MDA measurements (to reveal lipid peroxidation) were recorded after induction of anaesthesia (baseline), 60 and 120 min after cross-clamping of aorta (ischaemia phase), and 60 and 120 min after restoration of flow (reperfusion phase).


RESULTS
Dopexamine and dopamine at 8 microgkg(-1)min(-1) reduced MDA at 60 and 120 min after reperfusion.


CONCLUSIONS
Dopexamine seems superior to dopamine in reducing oxygen free radicals and subsequent lipid peroxidation during reperfusion after supraceliac aortic cross clamping in pigs.
Kostopanagiotou
G
G
2nd Department of Anaesthesiology, School of Medicine, Attikon Hospital, University of Athens, Chaidari, GR-12462 Athens, Greece.
Pandazi
A
A
Andreadou
I
I
Doufas
A
A
Chondroudaki
I
I
Kotsis
T
T
Rizos
D
D
Costopanagiotou
C
C
Smyrniotis
V
V
D000818:Animals; D017544:Aortic Aneurysm, Abdominal / Q000097:blood / Q000601:surgery*; D015415:Biomarkers / Q000097:blood; D004195:Disease Models, Animal; D004298:Dopamine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D005500:Follow-Up Studies; D007262:Infusions, Intravenous; D015227:Lipid Peroxidation / Q000187:drug effects* / Q000502:physiology; D008315:Malondialdehyde / Q000097:blood; D011446:Prospective Studies; D011897:Random Allocation; D015427:Reperfusion Injury / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D013552:Swine; D014656:Vascular Surgical Procedures / Q000009:adverse effects*
D015415:Biomarkers; D018491:Dopamine Agonists; C046318:dopexamine; D008315:Malondialdehyde; D004298:Dopamine